After cN-II silencing in the lung carcinoma cell line A549, we previously demonstrated a significant increase in triphosphorylated and diphosphorylated nucleoside compounds, whereas the nucleoside monophosphates remained unaffected [8]. The gene discussed is NT5C2; the disease is lung carcinoma.